Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
abbreviated, adding, AEs, age, baseline, CI, cough, death, Department, diarrhea, discontinuation, ensuing, exceeded, ezetimibe, fatigue, fight, Hazard, headache, HeFH, HR, hypercholesterolemic, hypothetical, infection, Inspector, Interval, median, MENDEL, mg, movement, myalgia, nausea, notable, older, parathyroidectomy, pathway, pioneer, placebo, predictor, quickly, Ratio, reaction, reserve, respiratory, rheumatoid, romosozumab, RUTHERFORD, Sequentially, showed, titled, tolerate, tract, transplant, turn, upper, ustekinumab, voluntarily, Week
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.2 Form of Award Notice - Grant of Stock Option Agreement
- 10.3 Form of Award Notice - Restricted Stock Unit Agreement
- 10.13 Fifth Amendment to the Amgen Supplemental Retirement Plan
- 10.22 Fourth Amendment to the Amgen Nonqualified Deferred Compensation Plan
- 31 Rule 13A-14(A) Certifications
- 32 Section 1350 Certifications
Related press release
AMGN similar filings
Filing view
External links